C71T
CANCELLED SECTION 71
01/02/2026
Back to search
Official data from USPTO
ACTIPHAGE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
01/27/2026
Trademark type
Word
Nice classes
1, 5
Filing date
02/02/2018
Registration date
06/18/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/02/2026
Last transaction
01/27/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
24
Owner location
GB
Examiner
MIRANDA, JOHN
Law office
N20
Current location
POST REGISTRATION
Holders and representatives
Holders
PBD Biotech Limited
Representatives
Rebecca Liebowitz VENABLE LLP
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicalbiochemical and biological productschemicalbiochemical and biological preparations used in science; chemical reagents; chemicals preparations for use as reagents; diagnostic preparationschemicalsreagents and chemical preparations for use in diagnostics; chemicalsreagents and chemical preparations for use in tests and testingreagents and chemical preparations for scientific purposes; diagnostic test kits for testing biological samples and foodstuffs for laboratory or research useresearch assaysall of the foregoing comprising of chemicalsreagents and chemical preparations; chemical research assays; diagnostic test kits for testing biological samples and foodstuffs for laboratory or research use and research assays for testing biological samplesall of the foregoing comprising of chemicals and chemical preparations; none being for medical or veterinary purposes
Class 5
Medical and veterinary preparations and substances for the diagnosis of infectious diseasesblood groupingvirologyantibodiesgeneticsoncologyhepatologypharmacogeneticscardiovascular medicinerespiratory ailments; chemicalbiochemical and biological preparations and reagents for medical and veterinary purposesmedical and veterinary preparations for the diagnosis of infectious diseasesblood groupingvirologyantibodiesgeneticsoncologyhepatologypharmacogeneticscardiovascular medicinerespiratory ailments; medical and veterinary preparations being chemical reagents; medical and veterinary diagnostic preparations; medical and veterinary testing preparations namelydiagnostic preparations; reagents for medical and veterinary diagnostic purposes; medical and veterinary preparations for the diagnosis of infectious diseasesblood groupingvirologyantibodiesgeneticsoncologyhepatologypharmacogeneticscardiovascular medicinerespiratory ailments; diagnostic preparations for testing for and in relation to infectious diseasesblood groupingvirologyantibodiesgeneticsoncologyhepatologypharmacogeneticscardiovascular medicinerespiratory ailments; diagnostic kits comprised of medical diagnostic reagents and assays for testing of biological samples in the nature of tissue and bodily fluids and food samples for use in disease detectionfor and in relation to infectious diseasesblood groupingvirologyantibodiesgeneticsoncologyhepatologypharmacogeneticscardiovascular medicinerespiratory ailments in the medical and veterinary fields *; all of the aforesaid being preparations or substances exclusively for use in detecting bacterial infections in animals and humans as well as for detecting bacteria in food *
Publications
History of USPTO decisions and trademark events.
39 publications found
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/18/2024
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
10/06/2021
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
09/21/2021
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
01/21/2021
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
01/21/2021
PLGL
ASSIGNED TO PARALEGAL
01/21/2021
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
05/28/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/18/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/27/2019
FIMP
FINAL DISPOSITION PROCESSED
09/27/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/18/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
06/18/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/02/2019
PUBO
PUBLISHED FOR OPPOSITION
04/02/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/13/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/22/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/05/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/05/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
02/05/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
12/17/2018
GNFR
FINAL REFUSAL E-MAILED
12/17/2018
CNFR
FINAL REFUSAL WRITTEN
12/17/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/12/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/12/2018
ALIE
ASSIGNED TO LIE
12/04/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/28/2018
RFNT
REFUSAL PROCESSED BY IB
06/23/2018
ATRV
ATTORNEY REVIEW COMPLETED
06/20/2018
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
06/20/2018
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
06/15/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/31/2018
RFRR
REFUSAL PROCESSED BY MPU
05/31/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/24/2018
CNRT
NON-FINAL ACTION WRITTEN
05/23/2018
DOCK
ASSIGNED TO EXAMINER
05/16/2018
MAFR
APPLICATION FILING RECEIPT MAILED
04/17/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/13/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/12/2018
Continuous trademark protection
Get notified about every new filing that threatens ACTIPHAGE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.